Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Hand-held, dilation-free, electroretinography in children under 3 years of age treated with vigabatrin.

Ji X, McFarlane M, Liu H, Dupuis A, Westall CA.

Doc Ophthalmol. 2019 Jun;138(3):195-203. doi: 10.1007/s10633-019-09684-9. Epub 2019 Mar 2.

PMID:
30826910
2.

Demonstration of anatomical development of the human macula within the first 5 years of life using handheld OCT.

Alabduljalil T, Westall CA, Reginald A, Farsiu S, Chiu SJ, Arshavsky A, Toth CA, Lam WC.

Int Ophthalmol. 2019 Jul;39(7):1533-1542. doi: 10.1007/s10792-018-0966-3. Epub 2018 Jun 23.

PMID:
29936688
3.

VIGABATRIN TOXICITY IN INFANCY IS ASSOCIATED WITH RETINAL DEFECT IN ADOLESCENCE: A Prospective Observational Study.

Wright T, Kumarappah A, Stavropoulos A, Reginald A, Buncic JR, Westall CA.

Retina. 2017 May;37(5):858-866. doi: 10.1097/IAE.0000000000001246.

PMID:
27552291
4.

Measuring recovery of visual function in children with papilledema using sweep visual evoked potentials.

Mezer E, Westall CA, Mirabella G, Wygnanski-Jaffe T, Yagev R, Buncic JR.

J AAPOS. 2016 Jun;20(3):252-7. doi: 10.1016/j.jaapos.2016.03.010. Epub 2016 May 6.

PMID:
27164429
5.

Cone-Photoreceptor Density in Adolescents With Type 1 Diabetes.

Tan W, Wright T, Rajendran D, Garcia-Sanchez Y, Finkelberg L, Kisilak M, Campbell M, Westall CA.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6339-43. doi: 10.1167/iovs.15-16817.

PMID:
26517403
6.

Author Response.

Westall CA, Wright T.

Neurology. 2015 Aug 18;85(7):656. No abstract available.

PMID:
26505052
7.

Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.

Westall CA, Wright T, Cortese F, Kumarappah A, Snead OC 3rd, Buncic JR.

Neurology. 2014 Dec 9;83(24):2262-8. doi: 10.1212/WNL.0000000000001069. Epub 2014 Nov 7. Erratum in: Neurology. 2015 May 5;84(18):1911.

8.

OTX2 mutations cause autosomal dominant pattern dystrophy of the retinal pigment epithelium.

Vincent A, Forster N, Maynes JT, Paton TA, Billingsley G, Roslin NM, Ali A, Sutherland J, Wright T, Westall CA, Paterson AD, Marshall CR; FORGE Canada Consortium, Héon E.

J Med Genet. 2014 Dec;51(12):797-805. doi: 10.1136/jmedgenet-2014-102620. Epub 2014 Oct 7.

PMID:
25293953
9.

The characterization of retinal phenotype in a family with C1QTNF5-related late-onset retinal degeneration.

Vincent A, Munier FL, Vandenhoven CC, Wright T, Westall CA, Héon E.

Retina. 2012 Sep;32(8):1643-51. doi: 10.1097/IAE.0b013e318240a574.

PMID:
22277927
10.

Blue flash ERG PhNR changes associated with poor long-term glycemic control in adolescents with type 1 diabetes.

McFarlane M, Wright T, Stephens D, Nilsson J, Westall CA.

Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):741-8. doi: 10.1167/iovs.11-8263.

11.
12.

Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin.

Sergott RC, Westall CA.

Acta Neurol Scand Suppl. 2011;(192):48-56. doi: 10.1111/j.1600-0404.2011.01600.x. Review.

PMID:
22061180
13.

Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone?

McCoy B, Wright T, Weiss S, Go C, Westall CA.

J Child Neurol. 2011 Jun;26(6):729-33. doi: 10.1177/0883073810390213. Epub 2011 Feb 22.

14.

ISCEV standard for clinical electro-oculography (2010 update).

Marmor MF, Brigell MG, McCulloch DL, Westall CA, Bach M; International Society for Clinical Electrophysiology of Vision.

Doc Ophthalmol. 2011 Feb;122(1):1-7. doi: 10.1007/s10633-011-9259-0. Epub 2011 Feb 5.

PMID:
21298321
15.

Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.

Dracopoulos A, Widjaja E, Raybaud C, Westall CA, Snead OC 3rd.

Epilepsia. 2010 Jul;51(7):1297-304. doi: 10.1111/j.1528-1167.2010.02564.x. Epub 2010 Apr 2.

16.

Paradoxical robust visual evoked potentials in young patients with cortical blindness.

Wygnanski-Jaffe T, Panton CM, Buncic JR, Westall CA.

Doc Ophthalmol. 2009 Oct;119(2):101-7. doi: 10.1007/s10633-009-9176-7. Epub 2009 Jun 23.

PMID:
19548015
17.

Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.

Durbin S, Mirabella G, Buncic JR, Westall CA.

Invest Ophthalmol Vis Sci. 2009 Aug;50(8):4011-6. doi: 10.1167/iovs.08-3237. Epub 2009 Mar 11.

18.

Rod a-wave analysis using high intensity flashes adds information on rod system function in 25% of clinical ERG recordings.

Nilsson J, Wright T, Westall CA.

Vision Res. 2008 Aug;48(18):1920-5. doi: 10.1016/j.visres.2008.05.011. Epub 2008 Jun 30.

19.

Contrast sensitivity is reduced in children with infantile spasms.

Mirabella G, Morong S, Buncic JR, Snead OC, Logan WJ, Weiss SK, Abdolell M, Westall CA.

Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3610-5.

20.

Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.

Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2895-902.

PMID:
17525226
21.

Assessment of central retinal function in patients with advanced retinitis pigmentosa.

Gerth C, Wright T, Héon E, Westall CA.

Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1312-8.

PMID:
17325178
22.

Pediatric clinical visual electrophysiology: a survey of actual practice.

ISCEV Committee for Pediatric Clinical Electrophysiology Guidelines, Fulton AB, Brecelj J, Lorenz B, Moskowitz A, Thompson D, Westall CA.

Doc Ophthalmol. 2006 Nov;113(3):193-204. Epub 2006 Nov 16.

PMID:
17109158
23.

Eye-movement responses to disparity vergence stimuli with artificial monocular scotomas.

Eizenman M, Sapir-Pichhadze R, Westall CA, Wong AM, Lee H, Morad Y.

Curr Eye Res. 2006 Jun;31(6):471-80.

PMID:
16769606
24.

Color visual evoked potentials in children with type 1 diabetes: relationship to metabolic control.

Elia YT, Daneman D, Rovet J, Abdolell M, Lam WC, Till C, Erraguntla V, Rubab S, Lodha N, Westall CA.

Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4107-13.

PMID:
16249487
25.

Detecting ocular-visual function changes in diabetes.

Westall CA.

Br J Ophthalmol. 2005 Nov;89(11):1392-3. No abstract available.

26.

Vision abnormalities in young children exposed prenatally to organic solvents.

Till C, Westall CA, Koren G, Nulman I, Rovet JF.

Neurotoxicology. 2005 Aug;26(4):599-613.

PMID:
16054697
27.

Development of contrast sensitivity in infants with prenatal and neonatal thyroid hormone insufficiencies.

Mirabella G, Westall CA, Asztalos E, Perlman K, Koren G, Rovet J.

Pediatr Res. 2005 Jun;57(6):902-7. Epub 2005 Mar 17.

PMID:
15774837
28.

Reduced visual function associated with infantile spasms in children on vigabatrin therapy.

Hammoudi DS, Lee SS, Madison A, Mirabella G, Buncic JR, Logan WJ, Snead OC, Westall CA.

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):514-20.

29.

Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children.

Buncic JR, Westall CA, Panton CM, Munn JR, MacKeen LD, Logan WJ.

Ophthalmology. 2004 Oct;111(10):1935-42.

30.

A modified protocol for the assessment of visual function in patients with retinitis pigmentosa.

Lodha N, Westall CA, Brent M, Abdolell M, Héon E.

Adv Exp Med Biol. 2003;533:49-57.

PMID:
15180247
31.

Changes in the electroretinogram resulting from discontinuation of vigabatrin in children.

Westall CA, Nobile R, Morong S, Buncic JR, Logan WJ, Panton CM.

Doc Ophthalmol. 2003 Nov;107(3):299-309.

32.

Longitudinal changes in photopic OPs occurring with vigabatrin treatment.

Morong S, Westall CA, Nobile R, Buncic JR, Logan WJ, Panton CM, Abdolell M.

Doc Ophthalmol. 2003 Nov;107(3):289-97.

33.

Development of ERG responses: the ISCEV rod, maximal and cone responses in normal subjects.

Fulton AB, Hansen RM, Westall CA.

Doc Ophthalmol. 2003 Nov;107(3):235-41.

PMID:
14711155
34.

Assessment of visual functions following prenatal exposure to organic solvents.

Till C, Rovet JF, Koren G, Westall CA.

Neurotoxicology. 2003 Aug;24(4-5):725-31.

PMID:
12900086
35.

Pontocerebellar hypoplasia type 1: new leads for an earlier diagnosis.

Salman MS, Blaser S, Buncic JR, Westall CA, Héon E, Becker L.

J Child Neurol. 2003 Mar;18(3):220-5.

PMID:
12731647
36.

The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin.

Westall CA, Logan WJ, Smith K, Buncic JR, Panton CM, Abdolell M.

Doc Ophthalmol. 2002 Mar;104(2):133-49.

37.

Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases.

Klinger G, Morad Y, Westall CA, Laskin C, Spitzer KA, Koren G, Ito S, Buncic RJ.

Lancet. 2001 Sep 8;358(9284):813-4.

PMID:
11564493
38.

Values of electroretinogram responses according to axial length.

Westall CA, Dhaliwal HS, Panton CM, Sigesmun D, Levin AV, Nischal KK, Héon E.

Doc Ophthalmol. 2001 Mar;102(2):115-30.

PMID:
11518455
39.
40.

Use of the Mollon-Reffin minimalist color vision test with young children.

Shute RH, Westall CA.

J AAPOS. 2000 Dec;4(6):366-72.

PMID:
11124673
41.

Comparison of techniques for detecting visually evoked potential asymmetry in albinism.

Soong F, Levin AV, Westall CA.

J AAPOS. 2000 Oct;4(5):302-10.

PMID:
11040481
43.

Time courses for maturation of electroretinogram responses from infancy to adulthood.

Westall CA, Panton CM, Levin AV.

Doc Ophthalmol. 1998-1999;96(4):355-79.

PMID:
10855811
44.

Electrophysiological evidence of cortical fusion in children with early-onset esotropia.

Eizenman M, Westall CA, Geer I, Smith K, Chatterjee S, Panton CM, Kraft SP, Skarf B.

Invest Ophthalmol Vis Sci. 1999 Feb;40(2):354-62.

PMID:
9950593
45.

Cortical binocularity and monocular optokinetic asymmetry in early-onset esotropia.

Westall CA, Eizenman M, Kraft SP, Panton CM, Chatterjee S, Sigesmund D.

Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1352-60.

PMID:
9660483
46.

The modified frisby stereotest.

Saunders KJ, Woodhouse JM, Westall CA.

J Pediatr Ophthalmol Strabismus. 1996 Nov-Dec;33(6):323-7.

PMID:
8934416
47.

A comparison of tests to determine acuity deficits in children with amblyopia.

Geer I, Westall CA.

Ophthalmic Physiol Opt. 1996 Sep;16(5):367-74.

PMID:
8944181
48.

Emmetropisation in human infancy: rate of change is related to initial refractive error.

Saunders KJ, Woodhouse JM, Westall CA.

Vision Res. 1995 May;35(9):1325-8.

49.

Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy.

Sigesmund DA, Weleber RG, Pillers DA, Westall CA, Panton CM, Powell BR, Héon E, Murphey WH, Musarella MA, Ray PN.

Ophthalmology. 1994 May;101(5):856-65.

PMID:
8190471
50.

Supplemental Content

Loading ...
Support Center